Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
DERM
$6.27
-6.28%
DERM
· Journey Medical Corp
$6.27
-0.42 (-6.28%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, as a result of recurring and historical losses, substantial doubt exists about the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$188.54M
Shares
28.22M
Volume · Oct 6
158.26K
Avg daily vol (3M)
182.66K
All webcasts
Earnings call · FY2023 Q4
Journey Medical Corp (DERM) Q4 2023 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$15.26M
-4.4% YoY
Net income · derived Q4
-$2.14M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 21, 2024 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 29, 2024 · complete as-filed document